Skip to main content
Clinical Trials/ACTRN12623001262695
ACTRN12623001262695
Recruiting
N/A

High flow nasal oxygen therapy versus conventional oxygen therapy in patients undergoing bronchoscopy and the effect on oxygenation: a randomised controlled trial

Georgia Burton0 sites120 target enrollmentDecember 5, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Georgia Burton
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 5, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Georgia Burton

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Indication for diagnostic bronchoscopy (standard bronchoscopy or EBUS guided)
  • Pre\-procedure intent to insert bronchoscope via the nose in the standard bronchoscopy group (stratum one)

Exclusion Criteria

  • Not able to consent
  • Patient is in ICU
  • Patient is in theatre
  • Patient is intubated
  • Patient has a tracheostomy
  • Pre\-procedure intent to insert bronchoscope via the mouth in the standard bronchoscopy group (stratum one)

Outcomes

Primary Outcomes

Not specified

Similar Trials